CXCL17 and neoplasm: CXCL17 is highly expressed in a variety of cancer cells, recruiting MDSCs into tumours and partially promoting tumour growth by enhancing angiogenesis.40 These findings are consistent with the shorter survival of SKCM patients with high CXCL17 documented in the current work.